OABI Company Profile and Key Details

Q: Who are the executives of OABI?

Dr. Christel Iffland Ph.D.Senior Vice President of Antibody TechnologiesDr. Douglas S. Krafte Ph.D.Senior Vice President of Ion Channels/Transporters & Icagen Ion Channel Technology Site HeadMs. Donna Ventura CPASenior Vice President of Corporation ControllerMs. Marie-Cecile van de Lavoir D.V.M., Ph.D.Senior Vice President of Technical Operations & GeneticsMs. Cia McCaffreyVice President of People & TalentDr. Bill Harriman Ph.D.Senior Vice President of Antibody Discovery

NASDAQ : OABI

OmniAb

$1.71

At Close 4:00 PM

61.59

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

OmniAb, Inc. (OABI) stock remained unchanged at $1.71 a share on NASDAQ. The stock opened at $1.70, fluctuating between $1.68 to $1.73 during the session.

Stock Snapshot

1.71

Prev. Close

184.03M

Market Cap

1.68

Day Low

-2.9

P/E Ratio

-0.59

EPS (TTM)

0.01

Cash Flow per Share

1.7

Open

107.62M

Number of Shares

1.73

Day High

70.05%

Free Float in %

3.14

Book Value

334.21K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Feb 18, 2026	1.70	1.73	1.68	1.71	342.21K
Feb 17, 2026	1.68	1.79	1.68	1.71	329.92K
Feb 13, 2026	1.70	1.82	1.69	1.70	351.1K
Feb 12, 2026	1.75	1.75	1.63	1.69	430.56K
Feb 11, 2026	1.75	1.78	1.69	1.70	176.28K
Feb 10, 2026	1.83	1.88	1.73	1.73	218.31K
Feb 09, 2026	1.68	1.82	1.67	1.79	322.96K
Feb 06, 2026	1.70	1.72	1.67	1.70	313.86K
Feb 05, 2026	1.72	1.86	1.64	1.65	503.41K
Feb 04, 2026	1.81	1.83	1.70	1.74	454.73K
Feb 03, 2026	1.78	1.84	1.74	1.76	339.51K
Feb 02, 2026	1.83	1.86	1.78	1.79	507.85K
Jan 30, 2026	1.85	1.92	1.77	1.82	734.06K
Jan 29, 2026	1.85	1.86	1.78	1.86	550.23K
Jan 28, 2026	1.95	1.96	1.76	1.85	1.08M
Jan 27, 2026	1.98	1.98	1.89	1.96	329.01K
Jan 26, 2026	1.98	1.99	1.93	1.95	416.63K
Jan 23, 2026	2.06	2.06	1.95	1.96	330.46K
Jan 22, 2026	2.02	2.10	2.02	2.07	213.93K
Jan 21, 2026	1.90	2.03	1.89	2.01	504.07K

Contact Details

EmeryVille, CA 94608

United States

https://www.omniab.com 510 250 7800

About Company

OmniAb, Inc., a biotechnology company, provides therapeutic antibody discovery technologies in the United States. The company's discovery platform provides industry partners access to the diverse antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company's OmniFlic (transgenic rat) and OmniClic (transgenic chicken) address industry needs for bispecific antibody applications though a common light chain approach, and OmniTaur that features unique structural attributes of cow antibodies for complex targets. The company was founded in 2012 and is headquartered in Emeryville, California.

Stock Peers

ARGX

1.8+0.21%

argenx SE$845.35 REGN

-1.37-0.17%

Regeneron Pharmaceuticals, Inc.$792.16 MDGL

4.17+0.86%

Madrigal Pharmaceuticals, Inc.$491.49 UTHR

-6.37-1.32%

United Therapeutics Corporation$476.05 VRTX

-7.01-1.47%

Vertex Pharmaceuticals Incorporated$470.31 ALNY

0.07+0.02%

Alnylam Pharmaceuticals, Inc.$332.68 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 PRAX

0.89+0.27%

Praxis Precision Medicines, Inc.$328.93 KRYS

-4.55-1.58%

Krystal Biotech, Inc.$283.29 SGEN

-0.16-0.07%

Seagen Inc.$228.74

Frequently Asked Questions

What is the current OmniAb, Inc. (OABI) stock price?

OmniAb, Inc. (NASDAQ: OABI) stock price is $1.71 in the last trading session. During the trading session, OABI stock reached the peak price of $1.73 while $1.68 was the lowest point it dropped to. The percentage change in OABI stock occurred in the recent session was 0% while the dollar amount for the price change in OABI stock was $0.00.

OABI's industry and sector of operation?

The NASDAQ listed OABI is part of Biotechnology industry that operates in the broader Healthcare sector. OmniAb, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of OABI?

Dr. Christel Iffland Ph.D.
Senior Vice President of Antibody Technologies
Dr. Douglas S. Krafte Ph.D.
Senior Vice President of Ion Channels/Transporters & Icagen Ion Channel Technology Site Head
Ms. Donna Ventura CPA
Senior Vice President of Corporation Controller
Ms. Marie-Cecile van de Lavoir D.V.M., Ph.D.
Senior Vice President of Technical Operations & Genetics
Ms. Cia McCaffrey
Vice President of People & Talent
Dr. Bill Harriman Ph.D.
Senior Vice President of Antibody Discovery

How OABI did perform over past 52-week?

OABI's closing price is 40.16% higher than its 52-week low of $1.22 where as its distance from 52-week high of $4.02 is -57.46%.

How many employees does OABI have?

Number of OABI employees currently stands at 114.

Link for OABI official website?

Official Website of OABI is: https://www.omniab.com

How do I contact OABI?

OABI could be contacted at phone 510 250 7800 and can also be accessed through its website. OABI operates from 5980 Horton Street, EmeryVille, CA 94608, United States.

How many shares of OABI are traded daily?

OABI stock volume for the day was 334.21K shares. The average number of OABI shares traded daily for last 3 months was 476.25K.

What is the market cap of OABI currently?

The market value of OABI currently stands at $184.03M with its latest stock price at $1.71 and 107.62M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	114
Beta	0.85
Sales or Revenue	$34.16M
5Y Sales Change%	1.148%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	114
Beta	0.85
Sales or Revenue	$34.16M
5Y Sales Change%	1.148%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

OABI Company Profile and Key Details

OmniAb

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Financial & Profitability Overview

Quarterly Financial Highlights

Technical Performance

Earnings & Analyst Outlook

Company Overview

Dividend & Fair Value

Shareholding & Insider Activity

Valuation Metrics

Price Forecast & Outlook

Key Takeaways